Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L ‐asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.

Hematological Oncology,Volume 0, Issue ja, -Not available-.

Source: Hematological Oncology - November 5, 2018 Category: Hematology Authors: Keisuke Kawamoto, Takaharu Suzuki, Takuya Kasami, Maiko Kiryu, Hirohito Sone, Hiroaki Miyoshi, Koichi Ohshima, Jun Takizawa Source Type: research